Registered entities
Corvus Pharmaceuticals, Inc.
Reg. No. 46-4670809United States
Korvus corporation S.E.
Reg. No. 29358698Czech Republic
Innovation
28 patent families (11 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 1,069 times.
| Year | Filings |
|---|---|
| 2017 | 3 |
| 2018 | 9 |
| 2019 | 11 |
| 2020 | 16 |
| 2021 | 15 |
| 2022 | 10 |
| 2023 | 4 |
| 2024 | 10 |
| 2025 | 9 |
Investor mix
15 investors on record; lead investors include Rock Springs Capital; 3 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 40% |
| Private equity | 3 | 20% |
| Bank & private debt | 1 | 7% |
| Other / undisclosed | 5 | 33% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
12 May 2026 · Executive Assistant · South San Francisco
Based on job postings tracked across public sources.